城地香江(603887.SH):聯合體中標中移動IDC算力設施項目
格隆匯6月26日丨城地香江(603887.SH)公佈,2024年6月24日,中國移動採購與招標網發佈了《中國移動長三角(揚州)數據中心算力基礎設施建維服務項目_中選候選人公示》,確定深圳中興通訊技術服務有限責任公司、公司全資子公司香江系統工程有限公司及上海啟斯雲計算有限公司中標中國移動長三角(揚州)數據中心算力基礎設施建維服務項目(簡稱“中移動IDC算力設施項目”)。根據已公開的中標信息,本次中移動IDC算力設施項目B01-B06機房樓預計共採購172.5MW,根據應答單價及預計的服務年限及綜合聯合體協議書當中關於工作量的約定進行計算,公司實得中標金額預計為33.04億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.